Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice

Journal of Clinical Investigation

Volumn 104, Issue 5, 1999, Pages 599-610

  Katz Levy, Yael ^a   Neville, Katherine L ^a   Girvin, Ann M ^a   Vanderlugt, Carol L ^a   Pope, Jonathan G ^a   Tan, Lit Jen ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DEMYELINATION; EPITOPE MAPPING; FEMALE; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; MYELINATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032752573     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7292     Document Type: Article

References (74)

1. Wekerle, H. 1993. Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease. Curr. Opin. Neurobiol. 3:779-784.
2. Ota, K., et al. 1990. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 346:183-187.
3. Bernard, C.C., and de Rosbo, N.K. 1991. Immunopathological recognition of autoantigens in multiple sclerosis. Acta Neurol. (Napoli). 13:171-178.
4. de Rosbo, N.K., et al. 1997. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions. Eur. J. Immunol. 27:3059-3069.
5. Kurtzke, J.F. 1993. Epidemiologic evidence for multiple sclerosis as an infection. Clin. Microbiol. Rev. 6:382-427.
6. Fujinami, R.S., and Oldstone, M.B. 1985. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 230:1043-1045.
7. Scherer, M.T., Ignatowicz, L., Winslow, G.M., Kappler, J.W., and Marrack, P. 1993. Superantigens: bacterial and viral proteins that manipulate the immune system. Annu. Rev. Cell Biol. 9:101-128.
8. Miller, S.D., and Gerety, S.J. 1990. Immunologic aspects of Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. Semin. Virol. 1:263-272.
9. Miller, S.D., et al. 1995. Evolution of the T cell repertoire during the course of experimental autoimmune encephalomyelitis. Immunol. Rev. 144:225-244.
10. Vanderlugt, C.L. and Miller, S.D. 1996. Epicope spreading. Curr. Opin. Immunol. 8:831-836.
11. Vanderlugt, C.L., Karandikar, N.J., Bluestone, J.A., and Miller, S.D. 1998. The functional significance of epitope spreading and its regulation by costimulatory interactions. Immunol. Rev. 164:63-72.
12. McRae, B.L., Kennedy, M.K., Tan, L.J., Dal Canto, M.C., and Miller, S.D. 1992. Induction of active and adoptive chronic-relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J. Neuroimmunol. 38:229-240.
13. McRae, B.L., Vanderlugt, C.L., Dal Canto, M.C., and Miller, S.D. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75-85.
14. Miller, S.D., et al. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epirope spreading. Nat. Med. 3:1133-1136.
15. Lipton, H.L., Kratochvil, J., Sethi, P., and Dal Canto, M.C. 1984. Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology. 34:1117-1119.
16. Clatch, R.J., Miller, S.D., Metzner, R., Dal Canto, M.C., and Lipton, H.L. 1990. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology. 176:244-254.
17. Lipton, H.L., Twaddle, G., and Jelachich, M.L. 1995. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:2525-2533.
18. Lipton, H.L., and Gonzalez-Scarano, F. 1978. Central nervous system immunity in mice infected with Theiler's virus. I. Local neutralizing antibody response. J. Infect. Dis. 137:145-151.
19. Dal Canto, M.C., and Lipton, H.L. 1982. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106:20-29.
20. Dal Canto, M.C., and Barbano, R.L. 1985. Immunocytochemical localization of MAG, MBP and P0 protein in acute and relapsing demyelinating lesions of Theiler's virus infection. J. Neuroimmunol. 10:129-140.
21. Lipton, H.L., and Dal Canto, M.C. 1979. Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect. Immun. 26:369-374.
22. Miller, S.D., et al. 1990. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J. Neuroimmunol. 26:9-23.
23. Miller, S.D., Clatch, R.J., Pevear, D.C., Trotter, J.L., and Lipton, H.L. 1987. Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. I. Cross-specificity among TMEV substrains and related picornaviruses, but not myelin proteins. J. Immunol. 138:3776-3784.
24. + T cell line specific for an immunodominant VP2 epitope. J. Immunol. 152:919-929.
25. Karpus, W.J., Pope, J.G., Peterson, J.D., Dal Canto, M.C., and Miller, S.D. 1995. Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J. Immunol. 155:947-957.
26. + T cell-mediated pathology. J. Immunol. 156:4050-4058.
27. Elliott, E.A., et al. 1997. Immune tolerance mediated by recombinant proteolipid protein prevents experimental autoimmune encephalomyelitis. J. Neuroimmunol. 79:1-11.
28. Elliott, E.A., et al. 1996. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J. Clin. Invest. 98:1602-1612.
29. Lipton, H.L., and Melvold, R. 1984. Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice. J. Immunol. 132:1821-1825.
30. Lipton, H.L., and Dal Canto, M.C. 1976. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J. Neurol. Sci. 30:201-207.
31. Pope, J.G., Vanderlugt, C.L., Lipton, H.L., Rahbe, S.M., and Miller, S.D. 1998. Characterization of and functional antigen presentation by central nervous system mononudear cells from mice infected with Theiler's murine encephalomyelitis virus. J. Virol. 72:7762-7771.
32. Karandikar, N.J., et al. 1998. Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J. Immunol. 161:192-199.
33. Lenschow, D.J., Walunas, T.L., and Bluestone, J.A. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14:233-258.
34. Perry, V.H., Hume, D.A., and Gordon, S. 1985. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience. 15:313-326.
35. Ford, A.L., Goodsall, A.L., Hickey, W.F., and Sedgwick, J.D. 1995. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154:4309-4321.
36. Ebers, G.C., and Sadovnick, A.D. 1993. The geographic distribution of multiple sclerosis: a review. Neuroepidemiology. 12:1-5.
37. Wucherpfennig, K.W., and Strominger, J.L. 1995. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:695-705.
38. Zhao, Z.-S., Granucci, E., Yeh, L., Schaffer, P.A., and Cantor, H. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science. 279:1344-1347.
39. Ufret-Vincenty, R.L., et al. 1998. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J. Exp. Med. 188:1725-1738.
40. Lehmann, P.V., Forsthuber, T., Miller, A., and Sercarz, E.E. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:155-157.
41. Yu, M., Johnson, J.M., and Tuohy, V.K. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
42. Tisch, R., et al. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:72-75.
43. Kaufman, D.L., et al. 1993. Spontaneous loss of T cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:69-72.
44. Tian, J., et al. 1996. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J. Exp. Med. 183:1561-1567.
45. Horwitz, M.S., et al. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-786.
46. Green, E.A., Eynon, E.E., and Flavell, R.A. 1998. Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity. 9:733-743.
47. Tian, J., Lehmann, P.V., and Kaufman, D.L. 1997. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186:2039-2043.
48. James, J.A., Gross, T., Scofield, R.H., and Harley, J.B. 1995. Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B′-derived PGMRPP and PGIRGP induce spliceosome autoimmunity. J. Exp. Med. 181:453-461.
49. Topfer, F., Gordon, T., and McCluskey, J. 1995. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens La (SS-B) and Ro (SS-A). Proc. Natl. Acad. Sci. USA. 92:875-879.
50. Chan, L.S., et al. 1998. Epitope spreading: lessons from autoimmune skin diseases. J. Invest. Dermatol. 110:103-109.
51. Tuohy, V.K., Yu, M., Weinstock-Guttman, B., and Kinkel, R.P. 1997. Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99:1682-1690.
52. Miller, S.D., et al. 1995. Blockade of CD28/B7-I interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:739-745.
53. Howard, L.M., et al. 1999. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J. Clin. Invest. 103:281-290.
54. Tan, L.J., Kennedy, M.K., and Miller, S.D. 1992. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition. J. Immunol. 148:2748-2755.
55. Smith Begolka, W., Vanderlugt, C.L., Rahbe, S.M., and Miller, S.D. 1998. Differential expression of inflammatory cytokines parallels progression of CNS pathology in two clinically distinct models of MS. J. Immunol. 4437-4446.
56. Fontana, A., Fierz, W., and Wekerle, H. 1984. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature. 307:273-276.
57. Tan, L.J., Gordon, K.B., Mueller, J.P., Matis, L.A., and Miller, S.D. 1998. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/J astrocytes. J. Immunol. 160:4271-4279.
58. Frei, K., et al. 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma-treated microglial cells. Eur. J. Immunol. 17:1271-1278.
59. + T lymphocytes in the central nervous system. Clin. Exp. Immunol. 98:313-318.
60. Hinrichs, D.J., Wegmann, K.W., and Dietsch, G.N. 1987. Transfer of experimental allergic encephalomyelitis to bone marrow chimeras. Endothelial cells are not a restricting element. J. Exp. Med. 166:1906-1911.
61. Hickey, W.F., and Kimura, H. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science. 239:290-292.
62. Myers, K.J., Dougherty, J.P., and Ron, Y. 1993. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the induction of experimental autoimmune encephalomyelitis. J. Immunol. 151:2252-2260.
63. Cserr, H.F., and Knopf, P.M. 1992. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today. 13:507-512.
64. Broadwell, R.D., Baker, B.J., Ebert, P.S., and Mickey, W.F. 1994. Allografts of CNS tissue possess a blood-brain barrier. III. Neuropathological, methodological, and immunological considerations. Microsc. Res. Tech. 27:471-494.
65. Dal Canto, M.C., Melvold, R.W., Kim, B.S., and Miller, S.D. 1995. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection: a pathological and immunological comparison. Microsc. Res. Tech. 32:215-229.
66. Carson, M.J., Sutcliffe, J.G., and Campbell, I.L. 1999. Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J. Neurosci. Res. In press.
67. Aloisi, F., Ria, F., Penna, G., and Adorini, L. 1998. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 activation. J. Immunol. 160:4671-4680.
68. Hofman, F.M., et al. 1986. Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J. Immunol. 136:3239-3245.
69. Traugott, U., Reinherz, E.L., and Raine, C.S. 1983. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science. 219:308-310.
70. Traugott, U. 1987. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development. J. Neuroimmunol. 16:283-302.
71. Windhagen, A., et al. 1995. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD80), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182:1985-1996.
72. De Simone, R., et al. 1995. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J. Neuropathol. Exp. Neurol. 54:175-187.
73. Williams, K., Ulvestad, E., and Antel, J.P. 1994. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur. J. Immunol. 24:3031-3037.
74. Traugott, U., and Lebon, P. 1988. Demonstration of alpha, beta, and gamma interferon in active chronic multiple sclerosis lesions. Ann. NY Acad. Sci. 540:309-311.